AACI President Karen E. Knudsen, MBA, PhD, is resigning from Sidney Kimmel Cancer Center (SKCC) at Jefferson Health in Philadelphia. She will step down as AACI president and begin her new role as chief executive officer of the American Cancer Society (ACS) on Tuesday, June 1. Dr. Knudsen will be the first woman CEO to lead the 107-year-old organization and the American Cancer Society Cancer Advocacy Network (ACS CAN).
Randall F. Holcombe, MD, MBA, has been appointed director of The University of Vermont Cancer Center (UVMCC) and chief of the Division of Hematology and Oncology in the Department of Medicine. He joins UVMCC from the National Cancer Institute (NCI)-Designated University of Hawai'i Cancer Center, where he has served as director since 2016. Dr. Holcombe will begin his tenure on August 1. He succeeds Richard Galbraith, MD, PhD, and Chris Holmes, MD, PhD, who became interim co-directors of UVMCC in 2020.
Representatives Brian Higgins (D-NY) and Gus Bilirakis (R-FL) will be honored with the Cancer Research Ally Award at the 2021 AACI/AACR Hill Day, which will be held virtually on June 9. Both congressmen will deliver remarks as part of the event’s lunchtime programming.
Mary "Dicey" Jackson Scroggins, MA, will deliver the keynote presentation on Wednesday, July 14 during the 13th Annual AACI CRI Meeting. Scroggins, a 24-year ovarian cancer survivor and recent acute myeloid leukemia (AML) survivor, research advocate, and health activist, is driven by a commitment to global health equity.
Nominations are now being accepted for the 2021 AACI Cancer Health Equity Award. The award was created to recognize an individual or group who demonstrates exceptional leadership in promoting health equity, mitigating cancer disparities, and advocating for diversity and inclusion at their cancer center. The nomination period will close on Friday, May 28.
AACI invites you to promote your cancer center by purchasing an ad in the 13th Annual AACI CRI Meeting program. The digital program book offers an excellent opportunity to showcase your center while supporting the CRI meeting. Your cancer center’s program ad may highlight a conference or a new initiative, or celebrate the success of the center’s clinical trials office. Cancer centers may also include links to their website and any upcoming events.
The National Academy of Sciences has elected Mary Beckerle, PhD, Huntsman Cancer Institute CEO and distinguished professor of biology and oncological sciences at the University of Utah, as a member. Dr. Beckerle is among 120 newly elected members of the academy.
Lynne E. Maquat, PhD, the founding director of the Center for RNA Biology at the University of Rochester, has been honored with the 2021 Wolf Prize in Medicine. She shares the award with Joan Steitz, PhD, at Yale School of Medicine, and Adrian Krainer, PhD, at Cold Spring Harbor Laboratory.
Jeffrey I. Gordon, MD, has been awarded the George M. Kober Medal from the Association of American Physicians in recognition of his contributions to the field of gut microbiome research. Dr. Gordon, a research member of Siteman Cancer Center, is considered to be the father of the field.
The Case Comprehensive Cancer Center congratulates the Cleveland Clinic's Nima Sharifi, MD, on his selection as the 2021 recipient of the American Association for Cancer Research (AACR) Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research.
Duke Cancer Institute physician assistant Scott Balderson, PA-C, has begun his term as president of the national Association of Physician Assistants in Cardiothoracic and Vascular Surgery. The association has more than 700 members and supports advocacy, medical education, and professional recertification.
The American Association for Cancer Research has named Jen-Tsan Ashley Chi, MD, PhD, as co-winner of the Molecular Cancer Research Michael B. Kastan Award for Research Excellence on behalf of his all-Duke research team for their paper, "A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer."
Rutgers Cancer Institute of New Jersey deputy director, Eileen White, PhD, has been elected to the 2021 class of Fellows of the American Association for Cancer Research (AACR) Academy.
A $10 million grant from the AbbVie Foundation will support scientific and educational activities at the University of Chicago Medicine Comprehensive Cancer Center under the leadership of newly appointed director, Kunle Odunsi, MD, PhD.
Mount Sinai researchers have received a grant award to lead a collaborative team of New York institutions in an initiative that addresses disparities in the participation of Black, indigenous, and people of color in cancer clinical trials. Stand Up To Cancer® awarded $6 million to a multi-institutional team that will be led by Nina Bickell, MD, MPH.
Researchers from Case Western Reserve University, New York University, and University Hospitals have been awarded a five-year, $3 million National Cancer Institute grant to develop and apply artificial intelligence (AI) tools for predicting which lung cancer patients will respond to immunotherapy.
Several Cancer Center at Illinois members are joining forces with scientists from the Mayo Clinic and Georgetown University on an expansive project targeting improved treatment for glioblastoma. The team, led by Brendan Harley, PhD, recently received a $3 million grant from the National Cancer Institute for their research.
A $2.7 million U.S. Department of Defense Ovarian Cancer Academy Leadership Award has been awarded to Nita Maihle, PhD. She shares the award with Douglas Levine, MD, a gynecologic oncologist at New York University.
Funded by a two-year, $2.08 million grant from the National Cancer Institute, a new collaboration between two western New York cancer research leaders will help oncologists learn whether Black and white cancer patients respond differently to a game-changing immunotherapy treatment.
In 2019, Cancer Center at Illinois (CCIL) member Prasanth Kumar V. Kannanganattu, PhD, received a $250,000 CCIL Seed Grant to support his research on the characterization of oncogenic noncoding RNAs in breast cancer progression and metastasis. The project has now been further funded by a $1.25 million National Institutes of Health (NIH) Research Grant.
Dan Theodorescu, MD, PhD, director of Cedars-Sinai Cancer, and Peter Kuhn, PhD, director of the Convergent Science Institute in Cancer at the USC Michelson Center for Convergent Bioscience, have received the inaugural Virtual Cancer Center Director Award to establish the Convergent Science Virtual Cancer Center. The center will guide emerging scholars from diverse science backgrounds and institutions to accelerate their research and careers.
Chanita Hughes-Halbert, PhD, will join USC Norris Comprehensive Cancer Center as associate director for cancer equity, a newly created position. Her appointment begins July 1 and she joins USC from the Medical University of South Carolina.
Mark Juckett, MD, was appointed medical director of the Masonic Cancer Center Clinical Trials Office for the Cellular, Gene and Immunotherapy Initiative (CTO-CGI), succeeding Shernan Holtan, MD, who initiated the role. Dr. Juckett was recruited from the University of Wisconsin - Madison.
Wei Zheng, MD, PhD, MPH, has been named associate director for Population Sciences Research at Vanderbilt-Ingram Cancer Center. He replaces William Blot, PhD, who retired from the leadership position on April 1.
Thomas J. Kelly Jr., PhD, has been named associate director for cancer research training and education at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS). Dr. Kelly is an associate professor of pathology in the UAMS College of Medicine Department of Pathology and will become a full professor in July.
Taofeek K. Owonikoko, MD, PhD, will join the UPMC Hillman Cancer Center and Department of Medicine at the University of Pittsburgh as chief of the Division of Hematology/Oncology. He also will serve as associate director for translational research and co-leader of the Cancer Therapeutics Program at Hillman.
Xiongbin Lu, PhD, has been named co-program leader of the Experimental and Developmental Therapeutics (EDT) research program. He has made important discoveries promoting translational development of human cancer research, including breast cancer targeted therapy and immunotherapy.
Santosh Mohan, MMCi, CPHIMS, FHIMSS, has joined Moffitt Cancer Center as the new vice president of digital. This newly created position will be instrumental in Moffitt’s success as the cancer center accelerates its digital capabilities to advance cancer care, treatment, and research.
Roswell Park Comprehensive Cancer Center has appointed Agnes Witkiewicz, MD, as director of cancer genetics and genomics. She will also hold the John & Santa Palisano Endowed Chair of Cancer Genetics.
Justin M. Sacks, MD, has been named director of the Division of Plastic and Reconstructive Surgery at Washington University School of Medicine in St. Louis. Dr. Sacks will treat patients at Siteman Cancer Center.
Nataliya Uboha, MD, PhD, has been selected to lead the Cancer Therapy Discovery and Development program at the University of Wisconsin Carbone Cancer Center.
Merry Jennifer Markham, MD, FACP, FASCO, has been appointed as chief of the division of hematology and oncology in the UF College of Medicine. Dr. Markham has served as the associate director for medical affairs for the UF Health Cancer Center since 2017.
Neeraj Agarwal, MD, a physician-scientist at Huntsman Cancer Institute, has been appointed senior director of clinical research innovation, overseeing critical components of Huntsman's clinical research infrastructure.
A study led by The University of Kansas Cancer Center, with AlloVir, Certara, and Memorial Sloan Kettering Cancer Center, compares the economic burden, health resource utilization, and clinical outcomes among allogeneic hematopoietic stem cell transplant recipients with virus-associated hemorrhagic cystitis to those without virus-associated hemorrhagic cystitis. Joseph McGuirk, DO, is lead author.
A new study has found a substantial rise nationwide in new diagnoses at age 65 for lung, breast, colon, and prostate cancer, suggesting that many wait for Medicare to kick in before they seek care.
A new University of Florida study finds that male patients who have a single general physician were more likely to receive a prostate cancer screening test during a period when the test was not recommended by the U.S. Preventive Services Task Force.
A new study from UK Markey Cancer Center researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.
In a new paper, researchers at UC San Francisco and the Whitehead Institute describe a CRISPR-based tool called "CRISPRoff," which allows scientists to switch off almost any gene in human cells without making a single edit to the genetic code.
The immunotherapy agent pembrolizumab can provide clinical benefit to some patients with metastatic breast cancer whose tumors were found to have a high number of mutations, and whose cancer continued to progress with standard treatments.
Scientists at VCU Massey Cancer Center have identified a protein that operates in tandem with a specific genetic mutation to spur lung cancer growth and could serve as a therapeutic target to treat the disease.
Two studies led by Baylor College of Medicine shed new light on the unanswered question of why estrogen receptor-positive (ER+) breast cancer sometimes grows back in the bone and spreads to other tissues despite effective endocrine therapies directed at ER.
A study by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine suggests the rate of cancer recurrence or survival may be no different in treated versus untreated elderly patients diagnosed in the early stages of breast cancer.
Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years.
New research from the UVA Cancer Center’s Jogender Tushir-Singh, PhD, could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon, and triple-negative breast cancer, that ultimately failed in human clinical trials.
Using a field of mathematics designed mainly to study how digital and other forms of information are measured, stored, and shared, scientists at Johns Hopkins Medicine and Johns Hopkins Kimmel Cancer Center say they have uncovered a likely key genetic culprit in the development of acute lymphoblastic leukemia.
Early results from a chimeric antigen receptor (CAR) T cell immunotherapy trial led by researchers at the UCLA Jonsson Comprehensive Cancer Center found using a bilateral attack instead of the conventional single-target approach helps minimize treatment resistance, resulting in long-lasting remission for people with non-Hodgkin's B-cell lymphoma that has returned or not responded to treatment.
Analyzing tumors from more than 2,600 patients and 38 cancer types, researchers from The University of Texas MD Anderson Cancer Center and the international Pan-Cancer Analysis of Whole Genomes Consortium have characterized the extensive genetic diversity across cancer and within individual tumors.
Scientists at City of Hope have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma.
A Wilmot Cancer Institute team is launching a two-year research project to develop different types of text messages for smoking cessation, and then study them in clinical trials to find out what works best.
Cardiovascular disease-related mortality among prostate cancer patients is significantly higher among Black patients compared with white patients, according to research from the Sidney Kimmel Cancer Center at Jefferson Health.
Researchers at the Johns Hopkins Kimmel Cancer Center used machine learning techniques to detect mutational signatures in cancer patients. Their algorithm outperformed the current standard of analysis and revealed new mutational signatures associated with obesity.
People with ovarian cancer frequently receive aggressive end-of-life care despite industry guidelines that emphasize quality of life for those with advanced disease, according to a recent study.
In a new article, Moffitt Cancer Center researchers demonstrate how an important defect in STING gene expression in melanoma cells contributes to their evasion from immune cell detection and destruction.
Cancer starts with mutations in a cell’s DNA, but new UC San Francisco research shows that the endurance of a tumor relies on its ability to rapidly evolve and adapt to challenges brought about by the environment in which it grows.
Children and young adults who receive CAR T-cell therapy for acute lymphoblastic leukemia suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a new study finds.
The National Cancer Institute’s Genomic Data Commons, launched in 2016 by then-Vice President Joseph Biden and hosted at the University of Chicago, has become one of the largest cancer genomics resources, with more than 3.3 petabytes of data from more than 65 projects and over 84,000 anonymized patient cases.
VCU Massey Cancer Center researcher Suyun Huang, PhD, recently discovered how cholesterol becomes dysregulated in brain cancer cells and showed that the gene responsible for it could be a target for future drugs.
To advance studies of cell migration, Stanford researchers have worked to develop and test new types of material that closely imitate the real tissue that surrounds cells.
New data published by researchers at OSUCCC – James suggests that an oral drug currently used to treat neuromuscular diseases could also help prevent squamous cell skin cancer.
Arizona residents, including underserved and underrepresented populations, will have better access to cutting-edge cancer therapies as the University of Arizona Cancer Center offers its clinical trials at locations across the state. The network is a collaboration among communities, hospitals, and physicians that will enable the university’s clinical research to reach more patients.
Sameer Patel, MD, FACS, chief of the Division of Plastic and Reconstructive Surgery in the Department of Surgical Oncology at Fox Chase Cancer Center and the Temple University Health System, has co-authored a new textbook, Cosmetic Breast Surgery.
Fox Chase Cancer Center has begun utilizing a new program called MyCareCompass that is designed to support patients with necessary information about their care by sending that information directly to them.
A study at OSUCCC - James will evaluate how COVID-19 impacts the immune system of cancer patients. The study will look at whether the COVID-19 vaccine is less effective in cancer patients receiving certain therapies, and how long immunity lasts.
The University of Arkansas for Medical Sciences conducted more than 100,000 digital health visits following the COVID-19 outbreak, seeing its highest numbers of virtual consultations at the height of the pandemic and during a February winter storm, performing more than 4,500 digital health visits per week.